IBDEI0WL ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16139,0)
 ;;=J2997^^104^998^2^^^^1
 ;;^UTILITY(U,$J,358.3,16139,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16139,1,2,0)
 ;;=2^J2997
 ;;^UTILITY(U,$J,358.3,16139,1,3,0)
 ;;=3^ALTEPLASE RECOMBINANT 1MG
 ;;^UTILITY(U,$J,358.3,16140,0)
 ;;=J1094^^104^998^9^^^^1
 ;;^UTILITY(U,$J,358.3,16140,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16140,1,2,0)
 ;;=2^J1094
 ;;^UTILITY(U,$J,358.3,16140,1,3,0)
 ;;=3^DEXAMETHASONE ACETATE 1MG
 ;;^UTILITY(U,$J,358.3,16141,0)
 ;;=J1100^^104^998^10^^^^1
 ;;^UTILITY(U,$J,358.3,16141,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16141,1,2,0)
 ;;=2^J1100
 ;;^UTILITY(U,$J,358.3,16141,1,3,0)
 ;;=3^DEXAMETHASONE SODIUM PHOS 1MG
 ;;^UTILITY(U,$J,358.3,16142,0)
 ;;=J9395^^104^998^16^^^^1
 ;;^UTILITY(U,$J,358.3,16142,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16142,1,2,0)
 ;;=2^J9395
 ;;^UTILITY(U,$J,358.3,16142,1,3,0)
 ;;=3^FULVESTRANT INJ 25MG
 ;;^UTILITY(U,$J,358.3,16143,0)
 ;;=96402^^104^998^58^^^^1
 ;;^UTILITY(U,$J,358.3,16143,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16143,1,2,0)
 ;;=2^96402
 ;;^UTILITY(U,$J,358.3,16143,1,3,0)
 ;;=3^ZOLADEX IMPLANT
 ;;^UTILITY(U,$J,358.3,16144,0)
 ;;=J2794^^104^998^49^^^^1
 ;;^UTILITY(U,$J,358.3,16144,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16144,1,2,0)
 ;;=2^J2794
 ;;^UTILITY(U,$J,358.3,16144,1,3,0)
 ;;=3^RISPERIDONE INJ 0.5mg
 ;;^UTILITY(U,$J,358.3,16145,0)
 ;;=J2323^^104^998^40^^^^1
 ;;^UTILITY(U,$J,358.3,16145,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16145,1,2,0)
 ;;=2^J2323
 ;;^UTILITY(U,$J,358.3,16145,1,3,0)
 ;;=3^NATALIZUMAB INJ 1MG
 ;;^UTILITY(U,$J,358.3,16146,0)
 ;;=J2426^^104^998^42^^^^1
 ;;^UTILITY(U,$J,358.3,16146,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16146,1,2,0)
 ;;=2^J2426
 ;;^UTILITY(U,$J,358.3,16146,1,3,0)
 ;;=3^PALIPERIDONE PALMITATE INJ 1MG
 ;;^UTILITY(U,$J,358.3,16147,0)
 ;;=J2315^^104^998^39^^^^1
 ;;^UTILITY(U,$J,358.3,16147,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16147,1,2,0)
 ;;=2^J2315
 ;;^UTILITY(U,$J,358.3,16147,1,3,0)
 ;;=3^NALTREXONE,DEPOT FORM INJ 1MG
 ;;^UTILITY(U,$J,358.3,16148,0)
 ;;=J1446^^104^998^15^^^^1
 ;;^UTILITY(U,$J,358.3,16148,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16148,1,2,0)
 ;;=2^J1446
 ;;^UTILITY(U,$J,358.3,16148,1,3,0)
 ;;=3^FILGRASTIM TBO 5MCG
 ;;^UTILITY(U,$J,358.3,16149,0)
 ;;=J1442^^104^998^14^^^^1
 ;;^UTILITY(U,$J,358.3,16149,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16149,1,2,0)
 ;;=2^J1442
 ;;^UTILITY(U,$J,358.3,16149,1,3,0)
 ;;=3^FILGRASTIM G-CSF 1MCG
 ;;^UTILITY(U,$J,358.3,16150,0)
 ;;=J3489^^104^998^59^^^^1
 ;;^UTILITY(U,$J,358.3,16150,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16150,1,2,0)
 ;;=2^J3489
 ;;^UTILITY(U,$J,358.3,16150,1,3,0)
 ;;=3^ZOLEDRONIC ACID 1MG
 ;;^UTILITY(U,$J,358.3,16151,0)
 ;;=Q3027^^104^998^23^^^^1
 ;;^UTILITY(U,$J,358.3,16151,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16151,1,2,0)
 ;;=2^Q3027
 ;;^UTILITY(U,$J,358.3,16151,1,3,0)
 ;;=3^INTERFERON BETA IM 1MCG
 ;;^UTILITY(U,$J,358.3,16152,0)
 ;;=Q3028^^104^998^24^^^^1
 ;;^UTILITY(U,$J,358.3,16152,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16152,1,2,0)
 ;;=2^Q3028
 ;;^UTILITY(U,$J,358.3,16152,1,3,0)
 ;;=3^INTERFERON BETA SQ 1MCG
 ;;^UTILITY(U,$J,358.3,16153,0)
 ;;=J1050^^104^998^32^^^^1
 ;;^UTILITY(U,$J,358.3,16153,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16153,1,2,0)
 ;;=2^J1050
 ;;^UTILITY(U,$J,358.3,16153,1,3,0)
 ;;=3^MEDROXYPROGESTERONE ACETATE 1 MG
 ;;^UTILITY(U,$J,358.3,16154,0)
 ;;=86580^^104^999^18^^^^1
 ;;^UTILITY(U,$J,358.3,16154,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16154,1,2,0)
 ;;=2^86580
 ;;^UTILITY(U,$J,358.3,16154,1,3,0)
 ;;=3^TB INTRADERMAL TEST
